- Home
- TDOC vs ANIP Comparison
TDOC vs ANIP Comparison
Compare TDOC & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDOC
- ANIP
- Stock Information
- Founded
- TDOC 2002
- ANIP 2001
- Country
- TDOC United States
- ANIP United States
- Employees
- TDOC N/A
- ANIP N/A
- Industry
- TDOC Medical/Nursing Services
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- TDOC Health Care
- ANIP Health Care
- Exchange
- TDOC Nasdaq
- ANIP Nasdaq
- Market Cap
- TDOC 1.3B
- ANIP 1.5B
- IPO Year
- TDOC 2015
- ANIP N/A
- Fundamental
- Price
- TDOC $7.11
- ANIP $66.30
- Analyst Decision
- TDOC Buy
- ANIP Strong Buy
- Analyst Count
- TDOC 19
- ANIP 8
- Target Price
- TDOC $9.71
- ANIP $80.13
- AVG Volume (30 Days)
- TDOC 5.4M
- ANIP 393.1K
- Earning Date
- TDOC 04-30-2025
- ANIP 05-09-2025
- Dividend Yield
- TDOC N/A
- ANIP N/A
- EPS Growth
- TDOC N/A
- ANIP N/A
- EPS
- TDOC N/A
- ANIP N/A
- Revenue
- TDOC $2,552,812,000.00
- ANIP $674,068,000.00
- Revenue This Year
- TDOC N/A
- ANIP $27.68
- Revenue Next Year
- TDOC $1.60
- ANIP $7.74
- P/E Ratio
- TDOC N/A
- ANIP N/A
- Revenue Growth
- TDOC N/A
- ANIP 30.27
- 52 Week Low
- TDOC $6.35
- ANIP $52.50
- 52 Week High
- TDOC $15.21
- ANIP $73.72
- Technical
- Relative Strength Index (RSI)
- TDOC 44.87
- ANIP 42.24
- Support Level
- TDOC $6.73
- ANIP $68.50
- Resistance Level
- TDOC $7.27
- ANIP $73.72
- Average True Range (ATR)
- TDOC 0.35
- ANIP 2.96
- MACD
- TDOC 0.08
- ANIP -0.43
- Stochastic Oscillator
- TDOC 55.24
- ANIP 3.08
About TDOC Teladoc Health Inc.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with Better convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.